SIAPS supported the MoHSS to design and implement a web-based electronic information system (dashboard) for both patient and stock status in Namibia. It was designed to improve coordination among facility, district, regional, and national stakeholders involved in HIV commodity management; increase the use of pharmaceutical information for management decision making at all levels of health care; and improve planning for financial resources for pharmaceutical commodities. The dashboard comprises a module for monitoring 22 pharmaceutical services delivery indicators, a module that summarizes the number of people accessing ART services, and an early warning system against stock-outs of antiretrovirals (ARVs) and other essential medicines.
Archive | LMISRSS feed for this section
Strengthening the Supply Chain Governance Framework for Pharmaceuticals and Health Products in the Philippines
The Department of Health (DOH) is ultimately responsible and accountable for ensuring that Filipinos have access to quality health services. An effective supply chain is essential for DOH to ensure that lifesaving health products are available, accessible, and effectively used for clients. Recently, the DOH has shown its commitment by creating the Supply Chain Management Unit (SCMU) in March 2016. SIAPS conducted a thorough desk review of previous assessments and DOH’s various internal SCM policies. SIAPS also helped coordinate meetings with various DOH offices to identify and validate current experiences in SCM and to obtain recommendations to strengthen SCM governance of DOH.
Supply chain constraints plague current neglected tropical disease (NTD) prevention and treatment programs. The rapid expansion of NTD control activities has not been without pharmaceutical and health system challenges. Inadequate NTD drug management in many countries has resulted in excess stocks, leading to waste resulting from drug expiry or stock-outs, leading to treatment interruption. SIAPS has received funding from USAID to support the Senegal MoH in strengthening the systems for NTD pharmaceutical management. The purpose of the technical assistance is to undertake a rapid assessment of the NTD pharmaceutical management system and understand the integration efforts. Technical review and recommendations have been provided by SIAPS personnel based in the SIAPS West Africa Offices and the office in Arlington, Virginia. SIAPS held meetings with the MoH NTD focal points and supply chain managers to ensure efficient delivery of technical support to the NTD programs, cross fertilization, sharing of lessons learned, challenges, and recommendations and to ensure that the implemented interventions are of the highest technical quality that focuses on country objectives.
This edition of the end-use verification (EUV) survey was conducted from August 9-31, 2016 under the leadership of the National Malaria Control Program (NMCP) in the regions of Southern and Central Mali. The survey aims to help improve the availability, management, and use of pharmaceuticals and other malaria commodities at public and quasi-public health facilities in Mali.
The main purpose of developing product codes for the PPM is to standardize and improve inventory management practices at the PPM, to provide input to the PPM’s product master list, and to integrate the list throughout the commodity information system. In addition, the codes will be used in the product catalogue for clients to order from.
Guidance on Elements to Consider when Planning for the Integration of Oxytocin into the EPI Cold Chain
The purpose of this document is to provide guidance to national program managers who are considering integrating oxytocin into the EPI cold chain. It is intended for representatives from relevant offices of the Ministry of Health (MoH), such as Pharmacy, Central Medical Stores, and Maternal and Child Health, as well as other policy makers, stakeholders, and implementing partners.
This guidance document introduces the pharmaceutical management elements that must be considered to successfully integrate oxytocin into the EPI cold chain and outlines the steps that will help national program managers plan the integration processes and strategies. Integrating oxytocin into the EPI cold chain may affect several elements within the pharmaceutical management cycle, from distribution systems, inventory management, and logistics management information systems and reporting procedures to roles and responsibilities, health facility infrastructure, and monitoring and evaluation. Some elements of the pharmaceutical system are afterthoughts that are only considered when challenges arise during implementation. Taking into account all elements that will be impacted by integrating oxytocin into a supply chain will not only help identify issues but also address needed changes in standard operating procedures and at the various stages of the supply chain. It is important to consider each element and address it in the strategy and implementation plan to ensure that oxytocin integration into the EPI cold chain is successful.
Coordinated Quantification of Health Commodities Helps Increase Availability of Medicines in Swaziland
Swaziland, working to combat two concurrent epidemics of HIV and tuberculosis (TB), has recently intensified nationwide HIV testing and TB case finding campaigns. However, these efforts have been hampered by routine stock-outs of key TB, laboratory, HIV and AIDS, and other health commodities. In December 2011, 50% of tracer products were stocked out at the central level, while 23% of tracer products were stocked out at health facility warehouses. The challenge of maintaining a consistent supply of commodities threatens not only current efforts to help curb the HIV and TB epidemics, but may also erode the progress made to date toward advancing prevention, diagnosis, and treatment services. The rapid scale-up of these programs as well as fiscal challenges in the health sector, have exposed weaknesses related to procurement and supply chain systems.
Absence of coordination mechanisms, lack of comprehensive guidelines, vertical programs and systems, and duplication of procurement practices impede effective procurement of medicines and health products in developing countries, frequently resulting in either too few or too many products on hand. In many low- and middle-income countries, such as Bangladesh, the logistics and management capabilities and systems are not sufficient to meet basic globally accepted standards and norms. However, pharmaceutical logistics management units offer a platform to help ensure not only a continuous supply of medicines and health supplies, but also coordinate procurement activities across the range of stakeholders involved, and build donor support by providing accurate data for decision making.
SIAPS is working to help governments, hospitals, and health facilities better manage data by strengthening the systems that support effective pharmaceutical information management. In addition to improving the collection, quality, and analysis of data, SIAPS is working in partnership with local stakeholders to develop informational dashboards which highlight and make available the key pieces of data needed for effective decision making.
PPM is a strategic health commodities supply chain entity for the government of Mali. It operates under a performance contract with the government that is renewable every three years. The performance contract expects PPM to offer public health facilities and programs the best possible service level in terms of product availability and quality service.
Since its inception, PPM has strived to offer the best possible supply chain services, particularly procurement and distribution of health commodities, to its clients. However, while providing services, PPM has experienced a number of challenges, such as a low service level for essential health commodities, inadequate funding, and inadequate HR capacity in terms of both numbers and skills.
With an understanding of the challenges and in response to various assessments, reviews, and recommendations from stakeholders, PPM asked for technical assistance from the USAID- funded SIAPS Program to guide the best strategies to improve and strengthen PPM’s supply chain and SOPs. In response, SIAPS conducted an in-depth analysis of the current PPM operations and identified issues to be addressed, with a focus on the entire PPM supply chain system rather than just one or two areas of intervention. Among the areas assessed was the PPM MIS.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]